Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
about
Elimination of visceral leishmaniasis on the Indian subcontinent.Parasite Carbohydrate Vaccines.VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.Coccinia grandis (L.) Voigt Leaf Extract Exhibits Antileishmanial Effect Through Pro-inflammatory Response: An In Vitro Study.Elimination of Kala-Azar from the Southeast Asia Region.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Marine Algae as Source of Novel Antileishmanial Drugs: A Review.Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.Clinical and Laboratory Analysis of Patients with Leishmaniasis: A Retrospective Study from a Tertiary Care Center in New Delhi.Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Evaluation of in vitro and in vivo antileishmanial potential of bergenin rich Bergenia ligulata (Wall.) Engl. root extract against visceral leishmaniasis in inbred BALB/c mice through immunomodulation.In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight.Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.Multi-target mode of action of a Clerodane-type diterpenoid from Polyalthia longifolia targeting African trypanosomes.Effect of iron-folic acid supplementation on change of hemoglobin among visceral Leishmaniasis patients in northwest Ethiopia: a retrospective follow up studyImportance of secondary screening with clinical isolates for anti-leishmania drug discovery
P2860
Q30244956-F0A0CF1C-5972-48BE-B035-EECBD620A922Q33785863-31433C8C-C6F3-4446-9F32-16F8225F8203Q38735051-AFC497A9-D226-4DC7-8739-B6DF874A0378Q38735055-6FAF86F4-47DA-42D2-BF83-639590B9396CQ39099665-6C86818E-0D97-4E58-A565-6A8991DEDF63Q46080853-4AC7FD29-86D6-4762-8026-BCFD2AA2F205Q46267456-38AA33A2-EF08-4C0B-BEBA-F359B3E8A153Q47349998-4C475FC3-D73F-4DFD-AA97-09F61848ACDBQ47556020-6A8C3AC8-686A-47F0-8551-EFF1FF365F4CQ49210114-27368C4D-F2EF-4294-8EC9-4F507374F13BQ49361617-7295E8BE-E1DE-452B-93BB-CEFAE1DA812DQ50051086-B70ED5F5-F2B5-4CF8-BDF1-5EFB21DD00C6Q50124215-6B3BC915-6FA0-4CE7-B615-1F74857E4799Q52593359-2BC1ABB2-7B6C-48BA-83DF-42CAF7342A68Q52726242-AF3E984B-F0CC-46C5-AF11-A3D412A877B0Q57921987-17EBE363-7694-4156-B2A9-DD0F7D1FE799Q57929890-F597D358-0909-4408-BD53-5834A99AA41C
P2860
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Current challenges in treatmen ...... a: a public health perspective
@ast
Current challenges in treatmen ...... a: a public health perspective
@en
Current challenges in treatmen ...... a: a public health perspective
@nl
type
label
Current challenges in treatmen ...... a: a public health perspective
@ast
Current challenges in treatmen ...... a: a public health perspective
@en
Current challenges in treatmen ...... a: a public health perspective
@nl
prefLabel
Current challenges in treatmen ...... a: a public health perspective
@ast
Current challenges in treatmen ...... a: a public health perspective
@en
Current challenges in treatmen ...... a: a public health perspective
@nl
P2093
P2860
P921
P1476
Current challenges in treatmen ...... a: a public health perspective
@en
P2093
Bhawana Singh
Jaya Chakravarty
Om Prakash Singh
P2860
P2888
P356
10.1186/S40249-016-0112-2
P407
P50
P5008
P577
2016-03-08T00:00:00Z
P5875
P6179
1002516598